Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2015 1
2017 1
2018 3
2019 2
2020 1
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
The Impact of a High-Carbohydrate/Low Fat vs. Low-Carbohydrate Diet on Performance and Body Composition in Physically Active Adults: A Cross-Over Controlled Trial.
Wachsmuth NB, Aberer F, Haupt S, Schierbauer JR, Zimmer RT, Eckstein ML, Zunner B, Schmidt W, Niedrist T, Sourij H, Moser O. Wachsmuth NB, et al. Among authors: aberer f. Nutrients. 2022 Jan 18;14(3):423. doi: 10.3390/nu14030423. Nutrients. 2022. PMID: 35276780 Free PMC article. Clinical Trial.
Results: After three weeks of each diet, VO2peak was comparable following both interventions (46.8 6.7 (HC) vs. 47.2 6.7 mL/kg/min (LC; p = 0.58)) while a significantly higher peak performance (251 43 W (HC) vs. 240 45 W (LC); (p = 0.0001), longer time to exhaustion …
Results: After three weeks of each diet, VO2peak was comparable following both interventions (46.8 6.7 (HC) vs. 47.2 6.7 mL/kg/min (LC; p = …
Oral Plasma Kallikrein Inhibitor for Prophylaxis in Hereditary Angioedema.
Aygören-Pürsün E, Bygum A, Grivcheva-Panovska V, Magerl M, Graff J, Steiner UC, Fain O, Huissoon A, Kinaciyan T, Farkas H, Lleonart R, Longhurst HJ, Rae W, Triggiani M, Aberer W, Cancian M, Zanichelli A, Smith WB, Baeza ML, Du-Thanh A, Gompels M, Gonzalez-Quevedo T, Greve J, Guilarte M, Katelaris C, Dobo S, Cornpropst M, Clemons D, Fang L, Collis P, Sheridan W, Maurer M, Cicardi M. Aygören-Pürsün E, et al. Among authors: aberer w. N Engl J Med. 2018 Jul 26;379(4):352-362. doi: 10.1056/NEJMoa1716995. N Engl J Med. 2018. PMID: 30044938 Free article. Clinical Trial.
Strong dose response after immunotherapy with PQ grass using conjunctival provocation testing.
Zielen S, Kuna P, Aberer W, Lassmann S, Pfaar O, Klimek L, Wade A, Kluehr K, Raab J, Wessiepe D, Lee D, Kramer MF, Gunawardena K, Higenbottam T, Heath MD, Skinner MA, de Kam PJ. Zielen S, et al. Among authors: aberer w. World Allergy Organ J. 2019 Oct 25;12(11):100075. doi: 10.1016/j.waojou.2019.100075. eCollection 2019 Nov. World Allergy Organ J. 2019. PMID: 31709029 Free PMC article.
[Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI-AeDA-GPA-DGAKI Position Paper (Pocket-Guide)].
Pfaar O, Klimek L, Worm M, Bergmann KC, Bieber T, Buhl R, Buters J, Darsow U, Keil T, Kleine-Tebbe J, Lau S, Maurer M, Merk H, Mösges R, Saloga J, Staubach P, Stute P, Rabe K, Rabe U, Vogelmeier C, Biedermann T, Jung K, Schlenter W, Ring J, Chaker A, Wehrmann W, Becker S, Mülleneisen N, Nemat K, Czech W, Wrede H, Brehler R, Fuchs T, Tomazic PV, Aberer W, Fink-Wagner A, Horak F, Wöhrl S, Niederberger-Leppin V, Pali-Schöll I, Pohl W, Roller-Wirnsberger R, Spranger O, Valenta R, Akdis M, Akdis C, Hoffmann-Sommergruber K, Jutel M, Matricardi P, Spertini F, Khaltaev N, Michel JP, Nicod L, Schmid-Grendelmeier P, Hamelmann E, Jakob T, Werfel T, Wagenmann M, Taube C, Gerstlauer M, Vogelberg C, Bousquet J, Zuberbier T. Pfaar O, et al. Among authors: aberer w. Laryngorhinootologie. 2020 Oct;99(10):676-679. doi: 10.1055/a-1170-8426. Epub 2020 Aug 21. Laryngorhinootologie. 2020. PMID: 32823368 German. No abstract available.
Safety and efficacy of immunotherapy with the recombinant B-cell epitope-based grass pollen vaccine BM32.
Niederberger V, Neubauer A, Gevaert P, Zidarn M, Worm M, Aberer W, Malling HJ, Pfaar O, Klimek L, Pfützner W, Ring J, Darsow U, Novak N, Gerth van Wijk R, Eckl-Dorna J, Focke-Tejkl M, Weber M, Müller HH, Klinger J, Stolz F, Breit N, Henning R, Valenta R. Niederberger V, et al. Among authors: aberer w. J Allergy Clin Immunol. 2018 Aug;142(2):497-509.e9. doi: 10.1016/j.jaci.2017.09.052. Epub 2018 Jan 17. J Allergy Clin Immunol. 2018. PMID: 29361332 Free PMC article. Clinical Trial.
Changes in pulmonary exercise haemodynamics in scleroderma: a 4-year prospective study.
Kovacs G, Avian A, Wutte N, Hafner F, Moazedi-Fürst F, Kielhauser S, Aberer E, Brodmann M, Graninger W, Foris V, Olschewski A, Olschewski H. Kovacs G, et al. Among authors: aberer e. Eur Respir J. 2017 Jul 13;50(1):1601708. doi: 10.1183/13993003.01708-2016. Print 2017 Jul. Eur Respir J. 2017. PMID: 28705939 Free article.
The primary end-point was the echocardiographic systolic pulmonary arterial pressure at 50 W exercise (sPAP(50)).We included 99 patients, of whom 58 had a complete dataset. ...In the RHC subgroup (n=28), mean (m)PAP and pulmonary vascular resistance at 50 W increase …
The primary end-point was the echocardiographic systolic pulmonary arterial pressure at 50 W exercise (sPAP(50)).We included 99 patie …
Effects of vitamin D on blood pressure and cardiovascular risk factors: a randomized controlled trial.
Pilz S, Gaksch M, Kienreich K, Grübler M, Verheyen N, Fahrleitner-Pammer A, Treiber G, Drechsler C, Ó Hartaigh B, Obermayer-Pietsch B, Schwetz V, Aberer F, Mader J, Scharnagl H, Meinitzer A, Lerchbaum E, Dekker JM, Zittermann A, März W, Tomaschitz A. Pilz S, et al. Among authors: aberer f. Hypertension. 2015 Jun;65(6):1195-201. doi: 10.1161/HYPERTENSIONAHA.115.05319. Epub 2015 Mar 23. Hypertension. 2015. PMID: 25801871 Clinical Trial.
European Surveillance System on Contact Allergies (ESSCA): Contact allergies in relation to body sites in patients with allergic contact dermatitis.
Oosterhaven JAF, Uter W, Aberer W, Armario-Hita JC, Ballmer-Weber BK, Bauer A, Czarnecka-Operacz M, Elsner P, García-Gavín J, Giménez-Arnau AM, John SM, Kręcisz B, Mahler V, Rustemeyer T, Sadowska-Przytocka A, Sánchez-Pérez J, Simon D, Valiukevičienė S, Weisshaar E, Schuttelaar MLA; ESSCA Working Group. Oosterhaven JAF, et al. Among authors: aberer w. Contact Dermatitis. 2019 May;80(5):263-272. doi: 10.1111/cod.13192. Epub 2019 Jan 14. Contact Dermatitis. 2019. PMID: 30520058 Free PMC article.
Effectiveness of icatibant for treatment of hereditary angioedema attacks is not affected by body weight: findings from the Icatibant Outcome Survey, a cohort observational study.
Caballero T, Zanichelli A, Aberer W, Maurer M, Longhurst HJ, Bouillet L, Andresen I; IOS Study Group. Caballero T, et al. Among authors: aberer w. Clin Transl Allergy. 2018 Mar 23;8:11. doi: 10.1186/s13601-018-0195-x. eCollection 2018. Clin Transl Allergy. 2018. PMID: 29599966 Free PMC article.
11 results